SAN FRANCISCO—The MiniMed 670G insulin pump, which its maker Medtronic touts as the world's first hybrid, closed-loop artificial pancreas, now has an application submitted before FDA, a Medtronic spokesperson confirms.
Medtronic officials expert a ruling from FDA within a year, Bloomberg reports.
"We are pleased we are making progress towards bringing this meaningful technology to people with diabetes in the country," says Medtronic spokesperson Janet Kim.
[Image courtesy of Medtronic]
The company's CEO Omar Ishrak had already told analysts that an application was expected before the end of 2016.
The 670G marks the fourth of six stages Medtronic is going through to develop what has been a holy grail for diabetes devices for decades: a almost entirely automatic "closed-loop" insulin pump system that does away with the constant glucose testing and insulin adjustments that diabetes patients presently go through.
Continue reading on EE Times' sister site, QMED.